10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001564590-19-017199`
Period End Date	20190331
Filing Date	20190508
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	arwr-20190331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 66 Cash Flow Statement 57 Stockholders Equity 34

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$30.13M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$161.64M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	94.67M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	88.51M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$69.81M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$13.42M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	88.51M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	94.67M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$327.38K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.76M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.27M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.59M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$640.12K	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$56.56M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$46.40M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$234.97M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$78.77M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.94M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.38M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$18.76M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$17.91M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$67.54M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$141.92K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$141.92K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$333.94M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$111.61M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.81M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.06M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.72M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.04M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$967.67K	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.94M	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$307.33K	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$173.95K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$600.00	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$90.89M	USD	Point-in-time
Note Payable	`NotesPayableCurrent`	$223.82K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$101.81M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$12.36M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.70M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.75M	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$29.73M	USD	Point-in-time
Note Payable, net of current portion	`LongTermNotesPayable`	$2.10M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$200.00K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$4.00M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$31.49M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 94,665,718 and 88,505,302 shares issued and outstanding as of March 31, 2019 and September 30, 2018, respectively	`CommonStockValue`	$180.88K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 94,665,718 and 88,505,302 shares issued and outstanding as of March 31, 2019 and September 30, 2018, respectively	`CommonStockValue`	$187.03K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$652.41M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$582.90M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-71.91K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-21.56K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-487.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-451.33M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$201.20M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$95.80M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$80.87M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.20M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$113.72M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$111.61M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$333.94M	USD	Point-in-time

Income Statement 66 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$48.15M	USD	1 Quarter
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$82.81M	USD	2 Qtrs
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$4.16M	USD	2 Qtrs
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$650.12K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$12.00M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$38.37M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$20.80M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$24.92M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$11.48M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.34M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$8.09M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.68M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$26.14M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$49.85M	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$33.01M	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$15.68M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$32.96M	USD	2 Qtrs
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-28.85M	USD	2 Qtrs
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-15.03M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$22.01M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$332.08K	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$168.35K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$2.98M	USD	2 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$1.89M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$432.14K	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-18.60K	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$764.22K	USD	2 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$1.89M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$2.98M	USD	2 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$149.75K	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$23.90M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-28.08M	USD	2 Qtrs
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-14.88M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$35.93M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	2 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-28.08M	USD	2 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$35.93M	USD	2 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$23.90M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-14.88M	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$0.25	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.18	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$0.39	USD	2 Qtrs
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.35	USD	2 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.18	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$0.37	USD	2 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$0.24	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.35	USD	2 Qtrs
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	92.62M	shares	2 Qtrs
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	94.16M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	84.08M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	79.41M	shares	2 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	79.41M	shares	2 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	84.08M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	97.21M	shares	2 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	98.08M	shares	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.97K	USD	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.56K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-50.34K	USD	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-28.16K	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-14.88M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$23.87M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-28.09M	USD	2 Qtrs
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$35.88M	USD	2 Qtrs

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$35.93M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-28.08M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-14.88M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$23.90M	USD	1 Quarter
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$432.14K	USD	2 Qtrs
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-18.60K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$3.55M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$5.32M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.29M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.35M	USD	2 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-330.23K	USD	2 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-346.34K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-51.51K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$13.09M	USD	2 Qtrs
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.44M	USD	2 Qtrs
Prepaid expenses and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.23M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$120.62M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-3.70M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.27M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.26M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-2.34M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-2.92M	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-196.43K	USD	2 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-240.74K	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-30.13M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$148.70M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$946.79K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$513.72K	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$90.27M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$5.02M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$23.70M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$12.24M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$18.17M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-78.97M	USD	2 Qtrs
Principal payments on notes payable	`RepaymentsOfNotesPayable`	$102.41K	USD	2 Qtrs
Principal payments on notes payable	`RepaymentsOfNotesPayable`	$2.42M	USD	2 Qtrs
Payments of taxes for net share settled restricted stock unit issuances	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$54.67K	USD	2 Qtrs
Proceeds from the exercises of warrants and stock options	`ProceedsFromExercisesOfWarrantsAndStockOptions`	$499.86K	USD	2 Qtrs
Proceeds from the exercises of warrants and stock options	`ProceedsFromExercisesOfWarrantsAndStockOptions`	$3.67M	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$60.52M	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$56.59M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$61.78M	USD	2 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$56.93M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$131.51M	USD	2 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$44.97M	USD	2 Qtrs
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$30.13M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$161.64M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$69.81M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$30.13M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$24.84M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$161.64M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$69.81M	USD	Point-in-time
Interest Paid	`InterestPaidNet`	$27.44K	USD	2 Qtrs
Interest Paid	`InterestPaidNet`	$88.54K	USD	2 Qtrs
Income Taxes Paid	`IncomeTaxesPaid`	$2.40K	USD	2 Qtrs
Income Taxes Paid	`IncomeTaxesPaid`	$2.40K	USD	2 Qtrs

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$80.87M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.20M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$113.72M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.60M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$3.55M	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.46M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.32M	USD	2 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.67M	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$193.12K	USD	2 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$193.12K	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.67M	USD	2 Qtrs
Exercise of stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	702,242.00	shares	2 Qtrs
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$218.22K	USD	1 Quarter
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$666.23K	USD	2 Qtrs
Common stock- Restricted Stock Units vesting, Amount	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-54.67K	USD	2 Qtrs
Common stock- Restricted Stock Units vesting, Amount	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-54.67K	USD	1 Quarter
Common stock issued	`StockIssuedDuringPeriodValueNewIssues`	$60.52M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.97K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.56K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-50.34K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-28.16K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$35.93M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-28.08M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-14.88M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$23.90M	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$80.87M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$70.20M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$113.72M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$171.50M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.